Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Second University of Naples; University of Campania "Luigi Vanvitelli"
• Collaborator: Napoli CTO Hospital
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• vitreous haemorrhage

• tractional retinal detachment

• active proliferative diabetic retinopathy.

Exclusion Criteria:

• neovascular glaucoma

• cataract

• combined traction and rhegmatogenous RD